Liver News and Research

RSS

Probiotics effectively prevent hepatic encephalopathy in patients with cirrhosis of the liver

Probiotics are effective in preventing hepatic encephalopathy in patients with cirrhosis of the liver, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. Hepatic encephalopathy is a deterioration of brain function that is a serious complication of liver disease.

9 Jun 2014

U.S. Preventive Services Task Force recommends hepatitis B screening for high risk individuals

A simple blood test can detect if a person is one of the two billion people worldwide infected with hepatitis B. And now the U.S. Preventive Services Task Force recommends that all teens and adults who are high risk for hepatitis B get screened for the infection.

6 Jun 2014

Regeneration of a chronically diseased liver may be possible, say Harvard researchers

Harvard Stem Cell Institute scientists at Boston Children's Hospital have new evidence in mice that it may be possible to repair a chronically diseased liver by forcing mature liver cells to revert back to a stem cell-like state.

6 Jun 2014

State highlights: NYC soda fight back in court; doc training slots in N.Y.; Texas inmate dialysis costs

New York City's battle over sugary drinks is entering its endgame. But much more than soda is at stake. A plan to limit the sale of large, high-calorie beverages, championed by former Mayor Michael R. Bloomberg as a novel way to fight obesity, went before the State Court of Appeals here on Wednesday, the city's final recourse after a lower court judge struck down the proposal last year (Grynbaum, 6/4).

6 Jun 2014

Gamma and neutron imaging safe and effective in simulations

Gamma and neutron imaging offer possible improvements over existing techniques such as X-ray or CT, but their safety is not yet fully understood.

5 Jun 2014

Soda consumers may get much higher dose of harmful sugar fructose than labels show

Soda consumers may be getting a much higher dose of the harmful sugar fructose than they have been led to believe, according to a new study by the Childhood Obesity Research Center (CORC) at the Keck School of Medicine of the University of Southern California (USC), part of Keck Medicine of USC.

5 Jun 2014

Researchers find way to prevent nonalcoholic fatty liver disease

Studying mice, researchers have found a way to prevent nonalcoholic fatty liver disease, the most common cause of chronic liver disease worldwide.

4 Jun 2014

New vaccine effective at preventing lung cancer in mice

Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.

4 Jun 2014

PsiOxus Therapeutics presents positive study results of anti-cancer vaccine Enadenotucirev at ASCO Annual Meeting

PsiOxus Therapeutics, Ltd. (PsiOxus), an award-winning biotechnology company developing innovative, novel treatments for cancer, announced that updates for its on-going international multicentre clinical program of the oncolytic vaccine enadenotucirev (previously known as ColoAd1) were presented at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.

4 Jun 2014

Researchers develop antibodies that reduce liver damage, recovers liver function

A Tainan-based research team from National Cheng Kung University (NCKU) has discovered the pathogenesis of liver fibrosis and developed antibodies that reduce liver damage, inhibit hepatic fibrosis, and recover liver function.

4 Jun 2014

FDA approves Can-Fite's study protocol for CF102 Phase II clinical trial for advanced liver cancer

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that the U.S. FDA has agreed with the Company's study protocol for its Phase II clinical trial of CF102 for the treatment of advanced liver cancer.

2 Jun 2014

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

A UCLA research team has discovered a new hormone called erythroferrone, which regulates the iron supply needed for red blood-cell production.

2 Jun 2014

New genes involved in taste perception effective in weight loss and improve quality of life

New understanding of the genes involved in taste perception and food preferences could lead to personalised nutrition plans effective not just in weight loss but in avoiding diseases such as cancer, depression, and hypertension, Italian researchers will tell the annual conference of the European Society of Human Genetics (ESHG) today (Monday).

2 Jun 2014

HCV reactivation may not worsen survival outcomes for lymphoma patients with HIV

More than a quarter of HIV+ patients are also infected with the Hepatitis C virus (HCV), which may complicate treatment and care decisions after a cancer diagnosis. The specifics of those complications haven't been well-researched in the past. Results from a new Fox Chase Cancer Center study on this patient population may start filling in that gap.

31 May 2014

Viewpoints: VA's problems begin with Congress; costly hepatitis drug may be a good buy

Politically, this critique of the VA is a no-brainer. After all, denying, delaying or incompetently delivering benefits to veterans who are entitled to them and have sacrificed so much for us is grotesque: the moral equivalent of kicking dogs and stealing food from children.

31 May 2014

Researchers make headway in fabricating blood vessels using 3D bioprinting technique

The tangled highway of blood vessels that twists and turns inside our bodies, delivering essential nutrients and disposing of hazardous waste to keep our organs working properly has been a conundrum for scientists trying to make artificial vessels from scratch.

31 May 2014

Perelman School wins $10M renewal to study oldest part of human immune system

The National Institute of Allergy and Infectious Diseases has awarded the Perelman School of Medicine at the University of Pennsylvania a five-year, $10 million renewal of a program project to study the oldest part of the human immune system called the complement system, or simply "complement."

30 May 2014

Researchers identify new therapeutic target for treating most common form of eye cancer

Researchers at the University of California, San Diego School of Medicine have identified a therapeutic target for treating the most common form of eye cancer in adults. They have also, in experiments with mice, been able to slow eye tumor growth with an existing FDA-approved drug.

30 May 2014

Biomedical scientists explore mechanisms of novel treatments for HCV

As new treatments for hepatitis C virus (HCV) are approved, biomedical scientists are exploring their mechanisms and what they reveal about the virus.

29 May 2014

First Edition: May 29, 2014

Today's early morning highlights from the major news organizations, including articles on an inspector general's report on care at VA hospitals and growing pressure from some House Republicans to vote on an alternative to the Affordable Care Act.

29 May 2014

Liver News and Research

Probiotics effectively prevent hepatic encephalopathy in patients with cirrhosis of the liver

U.S. Preventive Services Task Force recommends hepatitis B screening for high risk individuals

Regeneration of a chronically diseased liver may be possible, say Harvard researchers

State highlights: NYC soda fight back in court; doc training slots in N.Y.; Texas inmate dialysis costs

Gamma and neutron imaging safe and effective in simulations

Soda consumers may get much higher dose of harmful sugar fructose than labels show

Researchers find way to prevent nonalcoholic fatty liver disease

New vaccine effective at preventing lung cancer in mice

PsiOxus Therapeutics presents positive study results of anti-cancer vaccine Enadenotucirev at ASCO Annual Meeting

Researchers develop antibodies that reduce liver damage, recovers liver function

FDA approves Can-Fite's study protocol for CF102 Phase II clinical trial for advanced liver cancer

Findings could lead to treatments for blood disorders associated with iron deficiencies and overloads

New genes involved in taste perception effective in weight loss and improve quality of life

HCV reactivation may not worsen survival outcomes for lymphoma patients with HIV

Viewpoints: VA's problems begin with Congress; costly hepatitis drug may be a good buy

Researchers make headway in fabricating blood vessels using 3D bioprinting technique

Perelman School wins $10M renewal to study oldest part of human immune system

Researchers identify new therapeutic target for treating most common form of eye cancer

Biomedical scientists explore mechanisms of novel treatments for HCV

First Edition: May 29, 2014

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News